Mirror Biologics Patents – Insights & Stats (Updated 2024)

Mirror Biologics has a total of 67 patents globally, out of which 46 have been granted. Of these 67 patents, more than 86% patents are active. The United States of America is where Mirror Biologics has filed the maximum number of patents. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Mirror Biologics.

Mirror Biologics was founded in 2019. Mirror Biologics creates advanced vaccines and therapies that harness the immune system to fight cancer and infectious diseases.

Do read about some of the most popular patents of Mirror Biologics which have been covered by us in this article and also you can find Mirror Biologics patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Mirror Biologics patent portfolio.

How many patents does Mirror Biologics have?

Mirror Biologics has a total of 67 patents globally. These patents belong to 9 unique patent families. Out of 67 patents, 58 patents are active.

How Many Patents did Mirror Biologics File Every Year?

Mirror Biologics Patent Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantMirror Biologics Applications FiledMirror Biologics Patents Granted

How many Mirror Biologics patents are Alive/Dead?

Worldwide Patents

Mirror Biologics Patent Portfolio

How Many Patents did Mirror Biologics File in Different Countries?

Mirror Biologics Worldwide Patent Filing

Countries in which Mirror Biologics Filed Patents

United States Of America61

Where are Research Centers of Mirror Biologics Patents Located?

The Research Centers of Mirror Biologics Patents is the United States of America.

10 Best Mirror Biologics Patents

US7402431B2 is the most popular patent in the Mirror Biologics portfolio. It has received 111 citations so far from companies like Immunovative Therapies, Novartis, Agenus.

Below is the list of 10 most cited patents of Mirror Biologics:

Publication NumberCitation Count

What Percentage of Mirror Biologics US Patent Applications Were Granted?

Mirror Biologics (Excluding its subsidiaries) has filed 59 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 43 have been granted leading to a grant rate of 82.69%.

Below are the key stats of Mirror Biologics patent prosecution at the USPTO.

Which Law Firms Filed Most US Patents for Mirror Biologics?

Law FirmTotal ApplicationsSuccess Rate
Westman Champlin & Koehler PA5583.33%
Z Peter Sawicki475%

What are Mirror Biologics key innovation segments?

What Technologies are Covered by Mirror Biologics?

The chart below distributes patents filed by Mirror Biologics in different countries on the basis of the technology protected in patents. It also represents the markets where Mirror Biologics thinks it’s important to protect particular technology inventions.

R&D Focus: How has Mirror Biologics search focus changed over the years?


Interested in knowing about the areas of innovation that are being protected by Mirror Biologics?

Related Articles

MRM Patents – Insights & Stats (Updated 2024)

MRM has a total of 112 patents globally, out of which 64 have been granted. Of these 112 patents, more than 73% patents are active. United States of America is where MRM has filed the maximum number of patents, followed by China and Australia. Parallelly, Australia seems to be the

Read More »

I Peace Patents – Insights & Stats (Updated 2024)

I Peace has a total of 260 patents globally, out of which 53 have been granted. Of these 260 patents, more than 75% patents are active. Japan is where I Peace has filed the maximum number of patents, followed by The United States of America and Hong Kong (S.A.R.). Parallelly,

Read More »

Leave a Comment

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.